The solid tumor cancer stem cell consortium (Solid TUmor CaNceR Stem cEll network, SUNRiSE network) aims to bring together scientists with a common interest for the cancer stem cell field in solid tumors. These scientists are currently or plan to develop research programs that will decipher the cancer stem cell biology.
The SUNRiSE network originated from the desire for collaboration among CSC researchers in Marseille (Pr Emmanuelle Charaffe-Jauffret and Dr Christophe Ginestier, CRCM), Montpellier (Drs Julie Pannequin and Jean-Marc Pascussi, IGF), and Nice (Dr Thierry Virolle,iBV). This project is strongly supported by the Cancéropoles Grand Sud Ouest (Cancéropole GSO) and Provence Alpes Cotes d'Azur (Cancéropole PACA).
Our specific objectives:
- To aggregate expertise and resources to build a critical mass of researchers to accelerate the rate of research discoveries in the solid tumor CSC field.
- To promote collaborations in order to coordinate efficiently requests for grant applications (National and European)
- Expand researcher’s breakthroughs to a multi-disciplinary level with a “trans-pathology” interest
- Accelerate rate and intensity of cancer stem cell research findings and their translation to clinical application (attract clinicians and pharmaceutical companies to develop anti-CSC drug-based clinical trials).
Save the date :
The SUNRiSE network will organize is 2nd annual meeting entitled “Stem Cells and Cancer” in Montpellier from the 26th to the 27th of june 2017.
Final program Programme sunrise 2018